ÃÀ¸ß÷
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com



ÈýÔÂÃÀ¸ß÷½«Ö÷Àí1³¡ÏßÉÏÖ±²¥ÒÔ¼°¼ÓÈë4³¡º£ÄÚÍâ¾Û»á£¬£¬£¬£¬ÓëÄúÏßÉÏÏßÏÂÏà¼û¡£¡£¡£ÆÚ´ýÓëÄú´ºÅ¯»¨¿ªÊ±Ïà¾Û£¬£¬£¬£¬¹²»°Ç°ÑØ£¬£¬£¬£¬Í¬ÆôÑз¢Ð³̡£¡£¡£


2026Äê3ÔÂ12-14ÈÕ
ËÕÖݹú¼Ê²©ÀÀÖÐÐÄ
ÃÀ¸ß÷չλ #C3-088ºÅ
±¾´Î´ó»áÒÔ¡°Õ¹ÀÀ-´ó»á-Ô¼¼û-Ô˶¯¡±ËÄ´ó½¹µãϵͳ£¬£¬£¬£¬´î½¨ÁýÕÖÈ«¹¤ÒµÁ´µÄ¸ß¶Ë½»Á÷ÓëÏàÖúƽ̨¡£¡£¡£ÏÖ³¡½«Ô¼Çë30000+²Î»á¹ÛÖÚ£¬£¬£¬£¬40+ÍâÑó¹ú¼ÒºÍµØÇø£¬£¬£¬£¬850+Ñݽ²¼Î±ö£¬£¬£¬£¬ÉèÖÃ250+ϸ·ÖÂÛ̳£¬£¬£¬£¬3000+Ô¼¼û¸æ¿¢£¬£¬£¬£¬400+Õ¹É̲ÎÕ¹£¡
ÃÀ¸ß÷ÁÙ´²Ç°Ñо¿¸±×ܲÃÔøÏܳɲ©Ê¿½«¼ÓÈëÏÖ³¡Ô²×ÀÂÛ̳£º¶à˳Ӧ֢̽Ë÷¡ª¡ª´ÓADʧÀûµ½MASHÆÆ¾Ö¡£¡£¡£ÃÀ¸ß÷ÍŶӽ«ÔÚC3-088ÉèÕ¹£¬£¬£¬£¬³ÏÑûÄúݰÁÙÏÖ³¡½»Á÷£¡

2026Äê3ÔÂ19-20ÈÕ
³É¶¼ÎäºîÓ彻ʹÚãåÈÕÂùÝ
ÃÀ¸ß÷չλ #A26ºÅ
±¾´Î¾Û»á½«º¸Ç¿¹Ìå¡¢ADC£¬£¬£¬£¬¶àëÄ£¬£¬£¬£¬Ð¡·Ö×ÓÐÂÒ©£¬£¬£¬£¬ÉúÎïÒ©ÖÊÁ¿¹¤ÒÕµÈÑз¢ÁìÓòÇ°ÑØ¶¯Ì¬£¬£¬£¬£¬²¢¾Û½¹×îÐÂÁÙ´²Ï£Íû£¬£¬£¬£¬Ö¼ÔÚÍ»ÆÆÐÐÒµµÄÐÅÏ¢±ÚÀÝ£¬£¬£¬£¬Íƶ¯Á¢Òì¶àÔªÉú³¤£¡
ÃÀ¸ß÷Ê×ϯ¿ÆÑ§¹ÙÅíË«Çå½ÌÊÚ½«³öϯ±¾´Î¾Û»á²¢·¢ÌåÏÖ³¡Ñݽ²¡£¡£¡£ÃÀ¸ß÷ÍŶӽ«ÔÚA26È«³ÌÉèÕ¹£¬£¬£¬£¬³ÏÑûÄúݰÁÙÏÖ³¡½»Á÷£¡

March 22-25, 2026
San Diego Convention Center
Medicilon Booth #1324
Medicilon is excited to announce its participation in the SOT 2026! We¡¯re proud to have Dr. Hanjun Zou, TFM of Medicilon Chuansha site, lead our US team at this premier event in toxicology. With ~20 years of experience in preclinical safety assessment, Dr. Zou brings deep expertise in guiding preclinical programs from IND to NDA across a wide range of therapeutic modalities - including small molecules, peptides, antibodies, ADC, CGT, and more.
Visit us at Booth #1324 to explore how Medicilon¡¯s comprehensive toxicology and preclinical services can support your next milestone.

March 23-25, 2026
Lisbon, Portugal
Medicilon is Heading to Bio-Europe Spring 2026 in Lisbon!
Join us at one of the largest partnering conferences in the biopharma industry! Our VPs of Strategic Alliance & Business Development, Marshal Ma and Nadine Su, will both be on site to connect with partners and forge new collaborations.
Let¡¯s talk about:
Ïà¹ØÐÂÎÅ